Precigen (Germany) Top Insiders
I5X Stock | EUR 0.83 0.04 4.60% |
Precigen employs about 456 people. The company is managed by 21 executives with a total tenure of roughly 154 years, averaging almost 7.0 years of service per executive, having 21.71 employees per reported executive. Examination of Precigen's management performance can provide insight into the company performance.
Helen Sabzevari CEO President, Chief Executive Officer, President - Precigen, Inc. |
Randal Kirk Chairman Chairman of the Board, Chief Executive Officer |
Precigen |
Precigen Management Team Effectiveness
The company has return on total asset (ROA) of (0.1219) % which means that it has lost $0.1219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5132) %, meaning that it generated substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.Precigen Workforce Comparison
Precigen is currently regarded as number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 21,083. Precigen holds roughly 456 in number of employees claiming about 2.16% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.22 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of (0.52) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.52. Precigen Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Precigen Price Series Summation is a cross summation of Precigen price series and its benchmark/peer.
Precigen Notable Stakeholders
A Precigen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Precigen often face trade-offs trying to please all of them. Precigen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Precigen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Thomas Reed | Founder, Chief Science Officer | Profile | |
Helen Sabzevari | President, Chief Executive Officer, President - Precigen, Inc. | Profile | |
Randal Kirk | Chairman of the Board, Chief Executive Officer | Profile | |
Jeffrey Perez | Senior Vice President — Intellectual Property Affairs | Profile | |
Rick Sterling | Chief Financial Officer | Profile | |
Steven Frank | Independent Director | Profile | |
Jeffrey Kindler | Independent Director | Profile | |
Cesar Alvarez | Independent Director | Profile | |
Vinita Gupta | Independent Director | Profile | |
Fred Hassan | Independent Director | Profile | |
James Turley | Independent Director | Profile | |
Dean Mitchell | Independent Director | Profile | |
Robert Shapiro | Lead Independent Director | Profile | |
Rob Russell | VP HR | Profile | |
Donald Lehr | Chief Legal Officer | Profile | |
Rutul Shah | Chief Officer | Profile | |
Randal JD | Ex Chairman | Profile | |
Helen MPH | CEO Pres | Profile | |
Steven Harasym | VP Relations | Profile | |
Harry Thomasian | Chief Officer | Profile | |
Marie Rossi | VP Communications | Profile |
About Precigen Management Performance
The success or failure of an entity such as Precigen often depends on how effective the management is. Precigen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Precigen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Precigen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland. PRECIGEN INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 423 people.
Precigen Workforce Analysis
Traditionally, organizations such as Precigen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Precigen within its industry.Precigen Manpower Efficiency
Return on Precigen Manpower
Revenue Per Employee | 227.8K | |
Revenue Per Executive | 4.9M | |
Net Loss Per Employee | 202.1K | |
Net Loss Per Executive | 4.4M |
Complementary Tools for Precigen Stock analysis
When running Precigen's price analysis, check to measure Precigen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Precigen is operating at the current time. Most of Precigen's value examination focuses on studying past and present price action to predict the probability of Precigen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Precigen's price. Additionally, you may evaluate how the addition of Precigen to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |